Skip to content

Prospective, Multicenter, Single-Group, Clinical Trial Evaluating Anyreach Guide Wire for Coronary Stenotic Lesions

Prospective, Multicenter, Single-Group, Clinical Trial Evaluating Anyreach Guide Wire for Coronary Stenotic Lesions

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074115
Enrollment
Unknown
Registered
2023-07-31
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

single-arm group:use Anyreach Guide Wire during the procedure

Sponsors

Hunan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age = 18 years; 2. Clinical diagnosis of atherosclerotic coronary heart disease, to be treated with PCI; 3. Only one lesion in the target vessel requiring treatment; 4. If lesions in other vessels require treatment, they must be treated successfully before intervening the target lesion. 5. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Unprotected left main lesions; 2. Severe tortuosity or angulation of the vessel, etc. resulting in failure of the guidewire and/or balloon to pass through the lesion; 3. Pregnant or breastfeeding women; 4. Not suitable for inclusion in this trial as judged by the investigator.

Design outcomes

Primary

MeasureTime frame
device success rate;

Secondary

MeasureTime frame
acute procedure success rate;Number of serious adverse event;Number of serious adverse event;Number of device defect;

Countries

China

Contacts

Public ContactPan Hongwei

Hunan Provincial People's Hospital, China

panhongweihnsry@163.com+86 731 8392 9199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026